ClassID:

92788

C07C233/63 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups

Recent Application in this class:
#1
20260132119
2026-05-14

Alkylphenyl Substituted Compounds, Compositions and Methods of Use

#2
20260085034
2026-03-26

N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF

#3
20260055122
2026-02-26

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#4
20250359552
2025-11-27

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

#5
20250163227
2025-05-22

NUCLEATING AGENT FOR POLYOLEFIN RESIN, NUCLEATING AGENT COMPOSITION FOR POLYOLEFIN RESIN CONTAINING SAME, MASTER BATCH FOR POLYOLEFIN RESIN, POLYOLEFIN RESIN COMPOSITION, MOLDED ARTICLE THEREOF, FILM THEREOF, METHOD FOR PRODUCING POROUS FILM, AND PACKAGE

#6
20250134105
2025-05-01

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

#7
20250008960
2025-01-09

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

#8
20240360075
2024-10-31

N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF

#9
20240279159
2024-08-22

HERBICIDAL ARYLCYCLOPENTENE CARBOXAMIDES

#10
20240184199
2024-06-06

Onium Salt, Resist Composition, And Patterning Process

#11
20240158338
2024-05-16

COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME

#12
20230180761
2023-06-15

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#13
20220378772
2022-12-01

PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS

#14
20220348546
2022-11-03

SULFUR AND AMIDE TROPOLONE INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES THEREFOR

#15
20220340604
2022-10-27

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#16
20220081390
2022-03-17

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#17
20210403655
2021-12-30

Nucleating agent for polyolefin resin, nucleating agent composition for polyolefin resin containing same, master batch for polyolefin resin, polyolefin resin composition, molded article thereof, film thereof, method for producing porous film, and package

#18
20210163402
2021-06-03

Opioid receptor modulators and products and methods related thereto

#19
20210147365
2021-05-20

Analogs of fexaramine and methods of making and using

#20
20210147343
2021-05-20

OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO

#21
20210047347
2021-02-18

Modulators of Sestrin-GATOR2 interaction and uses thereof

#22
20210032195
2021-02-04

Farnesoid X receptor agonists and uses thereof

#23
20200239412
2020-07-30

NEW DERIVATES OF DHAA WITH ELECTROSTATIC TUNING

#24
20200196607
2020-06-25

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#25
20200172473
2020-06-04

DUAL MODULATORS OF FARNESOID X RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE

#26
20200123113
2020-04-23

Analogs of fexaramine and methods of making and using

#27
20200079800
2020-03-12

Modulators of Sestrin-GATOR2 interaction and uses thereof

#28
20190298668
2019-10-03

BICYCLIC ANALGESIC COMPOUNDS

#29
20190090488
2019-03-28

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#30
20190084939
2019-03-21

Analogs of fexaramine and methods of making and using

#31
20190062277
2019-02-28

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#32
20190048029
2019-02-14

Modulators of sestrin-GATOR2 interaction and uses thereof

#33
20180282263
2018-10-04

Farnesoid X receptor agonists and uses thereof

#34
20180251429
2018-09-06

Farnesoid X receptor agonists and uses thereof

#35
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#36
20180170858
2018-06-21

EPagonists as therapeutic compounds

#37
20180057447
2018-03-01

Methyl menthol derivative and cooling agent composition containing same

#38
20180042871
2018-02-15

Bicyclic analgesic compounds

#39
20180007911
2018-01-11

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#40
20180000087
2018-01-04

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#41
20170339961
2017-11-30

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#42
20170283347
2017-10-05

Adamantane derivative compound

#43
20170258122
2017-09-14

Organic compounds

#44
20170247409
2017-08-31

ABIETANE-TYPE DITERPENOIDS

#45
20170183293
2017-06-29

EP4 agonists as therapeutic compounds

#46
20170114080
2017-04-27

Modulators of sestrin-GATOR2 interaction and uses thereof

#47
20170066724
2017-03-09

Analogs of fexaramine and methods of making and using

#48
20170037044
2017-02-09

Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof

#49
20160374968
2016-12-29

Bicyclic analgesic compounds

#50
20160355462
2016-12-08

Bicyclic analgesic compounds

#51
20160304522
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#52
20160302418
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#53
20160302417
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#54
20160242444
2016-08-25

Organic compounds having taste-modifying properties

#55
20160122313
2016-05-05

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES

#56
20150174089
2015-06-25

Substituted aminobutyric derivatives as neprilysin inhibitors

#57
20150119426
2015-04-30

Modulators of the relaxin receptor 1

#58
20150094406
2015-04-02

Thermoplastic polymer composition

#59
20150087758
2015-03-26

Thermoplastic polymer composition

#60
20150045435
2015-02-12

COMPOUNDS AND METHODS FOR TREATING DIABETES

#61
20140336235
2014-11-13

Substituted biaryl alkyl amides

#62
20140322150
2014-10-30

Preventing or ameliorating agent for pigmentation

#63
20140296294
2014-10-02

Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases

#64
20140249306
2014-09-04

HIV replication inhibitor

#65
20140073662
2014-03-13

Spirocyclic nitriles as protease inhibitors

#66
20130102649
2013-04-25

Substituted biaryl alkyl amides

#67
20130072711
2013-03-21

Enantiomerically pure amines

#68
20120289512
2012-11-15

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#69
20120283326
2012-11-08

Anthranilic acid derivatives

#70
20120258063
2012-10-11

PREVENTING OR AMELIORATING AGENT FOR PIGMENTATION

#71
20120252830
2012-10-04

Substituted aminobutyric derivatives as neprilysin inhibitors

#72
20120122764
2012-05-17

Substituted carbamoylcycloalkyl acetic acid derivatives as NEP

#73
20120116113
2012-05-10

PROCESS FOR MAKING NEO-ENRICHED p-MENTHANE COMPOUNDS

#74
20120115841
2012-05-10

Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists

#75
20120088782
2012-04-12

LPA RECEPTOR ANTAGONIST

#76
20120078009
2012-03-29

Process for the preparation of cilastatin and sodium salt

#77
20120077959
2012-03-29

Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate

#78
20120059055
2012-03-08

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

#79
20120058123
2012-03-08

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

#80
20120015933
2012-01-19

Spirocyclic nitriles as protease inhibitors

#81
20120004228
2012-01-05

Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors

#82
20110263526
2011-10-27

Nitric Oxide Releasing Prodrugs of Therapeutic Agents

#83
20110160303
2011-06-30

N-ALKYLCARBONYL-AMINO ACID ESTER AND N-ALKYLCARBONYL-AMINO LACTONE COMPOUNDS AND THEIR USE

#84
20110152366
2011-06-23

-alkylcarbonyl-amino acid ester compounds and their use for skin irritation, itch, and pain

#85
20110136792
2011-06-09

NOVEL CARBOXYLIC ACID ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS

#86
20110098352
2011-04-28

N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

#87
20110092733
2011-04-21

Nateglinide crystals

#88
20110082204
2011-04-07

N-alkylcarbonyl-amino acid ester and N-alkylcarbonyl-amino lactone compounds and their use

#89
20110039852
2011-02-17

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#90
20110039812
2011-02-17

N-ALKYLCARBONYL-D-AMINO HYDROXYALKYL ESTER COMPOUNDS AND THEIR USE

#91
20100305145
2010-12-02

Substituted aminobutyric derivatives as neprilysin inhibitors

#92
20100305131
2010-12-02

Substituted aminopropionic derivatives as neprilysin inhibitors

#93
20100256414
2010-10-07

PROCESS FOR THE PREPARATION OF CHIRALLY PURE NATEGLINIDE

#94
20100249157
2010-09-30

LPA receptor antagonist

#95
20100129311
2010-05-27

PHENYLALANINE AMIDE INHIBITORS OF ATP-SENSITIVE POTASSIUM CHANNELS

#96
20100113462
2010-05-06

Substituted benzoylamino-indan-2-carboxylic acids and related compounds

#97
20100029767
2010-02-04

Anthranilic acid derivatives

#98
20090275523
2009-11-05

Spirocyclic nitriles as protease inhibitors

#99
20090258835
2009-10-15

Compounds that stimulate glucose utilization and methods of use

#100
20090253933
2009-10-08

Nateglinide crystals

#101
20090240052
2009-09-24

Anthranilic acid derivative or salt thereof

#102
20090238882
2009-09-24

Carbon-substituted diketopiperazine delivery systems

#103
20090215780
2009-08-27

Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity

#104
20090197959
2009-08-06

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#105
20090176783
2009-07-09

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#106
20090143614
2009-06-04

Process for the preparation of Cilastatin and sodium salt

#107
20090143469
2009-06-04

SALTS OF NATEGLINIDE

#108
20090076304
2009-03-19

METHODS FOR PRODUCING CARBOXYLIC ACID CHLORIDE COMPOUNDS

#109
20090076301
2009-03-19

METHODS FOR PRODUCING NATEGLINIDE CRYSTALS

#110
20090042918
2009-02-12

Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3

#111
20080319222
2008-12-25

Crystal forms of N- (trans-4-isopropylctyclohexylcarbonyl) -D-phenylalanine

#112
20080319075
2008-12-25

Polymorphic forms of nateglinide

#113
20080300314
2008-12-04

Cooling Compounds

#114
20080293764
2008-11-27

LPA receptor antagonist

#115
20080227857
2008-09-18

N-Alkylcarbonyl-Amino Acid Ester and N-Alkylcarbonyl-Amino Lactone Compounds and Their Use

#116
20080194867
2008-08-14

Nateglinide crystals

#117
20080167310
2008-07-10

MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR)

#118
20080132574
2008-06-05

BLT2-mediated disease, BLT2 binding agent and the compound

#119
20080096970
2008-04-24

Stable Nateglinide Form B Compositions

#120
20080081927
2008-04-03

CRYSTAL FORMS OF N-(TRANS-4-ISOPROPYLCYCLOHEXYLCARBONYL)-D-PHENYLALANINE

#121
20080045483
2008-02-21

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

#122
20080027134
2008-01-31

Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use

#123
20080008764
2008-01-10

CARBON-SUBSTITUTED DIKETOPIPERAZINE DELIVERY SYSTEMS

#124
20070259955
2007-11-08

Process for the preparation of nateglinide

#125
20070232829
2007-10-04

Methods for producing nateglinide B-type crystals

#126
20070219176
2007-09-20

Viral polymerase inhibitors

#127
20070179186
2007-08-02

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#128
20070167523
2007-07-19

Methods for producing nateglinide crystals

#129
20070142663
2007-06-21

T-butyl cascade polymers

#130
20070105913
2007-05-10

Alkynyl aryl carboxamides

#131
20070043117
2007-02-22

Process for the preparation of chirally pure N-(trans-4-is)

#132
20070004804
2007-01-04

Polymorphic forms of nateglinide

#133
20060276676
2006-12-07

Non-symmetrical gelling agent

#134
20060223879
2006-10-05

Non-steroidal farnesoid x receptor modulators

#135
20060205811
2006-09-14

Compounds that stimulate glucose utilization and methods of use

#136
20060173208
2006-08-03

Compounds that stimulate glucose utilization and methods of use

#137
20060155143
2006-07-13

Methods for producing acylphenylalanine

#138
20060154970
2006-07-13

Alanines compounds, method of preparing them and their use

#139
20060149070
2006-07-06

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#140
20060148902
2006-07-06

Process for the preparation of nateglinide, preferably in B-form

#141
20060148830
2006-07-06

LPA receptor antagonist

#142
20060134130
2006-06-22

Oral drug delivery compositions and methods

#143
20060128764
2006-06-15

Non-steroidal farnesoid X receptor modulators and methods for the use thereof

#144
20060074110
2006-04-06

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

#145
20060030553
2006-02-09

Cell adhesion inhibitors

#146
20060004102
2006-01-05

Polymorphic forms of nateglinide

#147
20050288338
2005-12-29

Amido compounds and their use as pharmaceuticals

#148
20050272815
2005-12-08

Compounds and compositions for delivering active agents

#149
20050256336
2005-11-17

Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine

#150
20050255138
2005-11-17

Active agent transport systems

#151
20050234129
2005-10-20

Salts of nateglinide

#152
20050228122
2005-10-13

Esteramide compositions, copolymers and blends thereof

#153
20050222256
2005-10-06

Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine

#154
20050187297
2005-08-25

Compounds, methods for their preparation and use thereof

#155
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#156
20050182133
2005-08-18

Compounds that stimulate glucose utilization and methods of use

#157
20050165114
2005-07-28

Benzene derivatives and pharmaceutical use thereof

#158
20050165108
2005-07-28

Form of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine

#159
20050143449
2005-06-30

Non-steroidal farnesoid X receptor modulators and methods for the use thereof

#160
20050142156
2005-06-30

Carbon-substituted diketopiperazine delivery systems

#161
20050113447
2005-05-26

Selective retinoid agonists

#162
20050101744
2005-05-12

T-butyl cascade polymers

#163
20050101672
2005-05-12

Nateglinide crystals

#164
20050101671
2005-05-12

Compounds and compositions for delivering active agents

#165
20050090552
2005-04-28

Polymorphic forms of nateglinide

#166
20050075400
2005-04-07

Polymorphic forms of nateglinide

#167
20050075378
2005-04-07

Modulators of peroxisome proliferator activated receptors (PPAR)

#168
20050014949
2005-01-20

Polymorphic forms of nateglinide

#169
20050014836
2005-01-20

Crystalline form of nateglinide

#170
20050010019
2005-01-13

Diaminodicarboxylic acids and intermediates thereof